Plenary Session – inactive due to federal service

4.67 Teclistimab for R/R Multiple Myeloma

38 min • 9 juni 2022
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates

Senaste avsnitt

Podcastbild

00:00 -00:00
00:00 -00:00